triazoles has been researched along with chalcone in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 20 (62.50) | 24.3611 |
| 2020's | 12 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chibale, K; Gut, J; Hans, RH; Rosenthal, PJ | 1 |
| Chibale, K; Egan, TJ; Guantai, EM; Gut, J; Ncokazi, K; Rosenthal, PJ; Smith, PJ | 1 |
| Bedi, PM; Kaur, T; Kumar, V; Mahajan, MP; Raj, R; Saxena, AK; Singh, P | 1 |
| Biot, C; Guérardel, Y; Kremer, L; Kumar, K; Kumar, V; Singh, P | 1 |
| Biot, C; Carrère-Kremer, S; Guérardel, Y; Kremer, L; Kumar, K; Kumar, V | 1 |
| Mandi, P; Nantasenamat, C; Pingaew, R; Prachayasittikul, S; Prachayasittikul, V; Ruchirawat, S; Saekee, A | 1 |
| Alam, S; Arigari, NK; Chinde, S; Chinthala, Y; Domatti, AK; Grover, P; Jonnala, KK; K V N S, S; Khan, F; Thakur, S; Tirunagari, S; Tiwari, A | 1 |
| Hong, G; Liu, T; Mao, L; Yang, X; Zhao, L | 1 |
| El Sayed Aly, MR; Mohamed, MA; Saad, HA | 1 |
| Agarwal, A; Agarwal, D; Awasthi, SK; Gupta, RD; Kant, R; Kumar, D; Tilak, R | 1 |
| Gut, J; Kumar, V; Rosenthal, PJ; Singh, A | 1 |
| Biot, C; Dupont, C; Kremer, L; Kumar, K; Kumar, V; Singh, A; Viljoen, A | 1 |
| Bhushan, S; Guru, SK; Jaglan, S; Kumar, A; Lal, K; Yadav, P | 1 |
| Ahmed, HEA; Alswah, M; Bayoumi, AH; Elgamal, K; Elmorsy, A; Ihmaid, S | 1 |
| Kumar, A; Lal, K; Paul, AK; Yadav, P | 1 |
| Cardona-G, W; Herrera-R, A; Yepes, AF | 1 |
| Kumar, A; Kumar, L; Kumar, R; Lal, K; Paul, AK; Yadav, P | 1 |
| Ali, I; Gomha, SM; Khalil, KD; Riyadh, SM | 1 |
| Jana, K; Manna, T; Misra, AK; Pal, K | 1 |
| Csámpai, A; Dembo, A; Duró, C; Jernei, T; Kőhidai, L; Lajkó, E; Schlosser, G; Takács, A | 1 |
| Bantu, R; Jain, N; Janardhan, S; Nagarapu, L; Vanaparthi, S | 1 |
| Abdel-Aziz, M; Abdelhamid, D; Fujita, M; Gouda, AM; Hassan, HA; Mohassab, AM; Otsuka, M; Tateishi, H; Youssif, BGM | 1 |
| Aboelnaga, A; Elabbady, S; Fahim, AM; Nassar, E; Soror, S | 1 |
| Cidade, H; Correia-da-Silva, M; Pereira, D; Pinto, M | 1 |
| Abulkhair, HS; Fayed, EA; Husseiny, EM; Othman, EM | 1 |
| Abbas, SH; Abd El-Hafeez, AA; Abourehab, MAS; Abuo-Rahma, GEA; Alhaj-Suliman, SO; Ebeid, K; Ghosh, P; Hayallah, AM; Mekkawy, AI; Mohammed, HHH; Salem, AK; Wafa, EI | 1 |
| Kamra, N; Kumar, D; Rani, S; Sangwan, PL; Singh, A; Singh, SK; Singh, V; Thakral, S | 1 |
| Maghraby, MT; Salem, OIA; Sheha, MM; Youssif, BGM | 1 |
| Cidade, H; Correia-da-Silva, M; Durães, F; Freitas-da-Silva, J; Martins-da-Costa, P; Pereira, D; Pinto, E; Pinto, M; Sousa, E; Spengler, G; Szemerédi, N | 1 |
| Ding, Q; Jiang, F; Lu, Y; Wang, H; Xia, Z; Zhang, C | 1 |
| Gong, Z; Su, Q; Tian, Z; Xu, B | 1 |
| Csala, M; Csámpai, A; Duró, C; Gurbi, B; Móra, I; Murányi, J; Németh, K; Simon, J; Varga, A | 1 |
2 review(s) available for triazoles and chalcone
| Article | Year |
|---|---|
Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
Topics: Antiprotozoal Agents; Chagas Disease; Chalcone; Humans; Hydrazones; Leishmaniasis; Pentamidine; Quinolines; Terpenes; Triazoles | 2018 |
Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Chalcone; Chemistry Techniques, Synthetic; Click Chemistry; Cycloaddition Reaction; Dimerization; Dose-Response Relationship, Drug; Flavonoids; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship; Triazoles | 2021 |
30 other study(ies) available for triazoles and chalcone
| Article | Year |
|---|---|
Comparison of the antiplasmodial and falcipain-2 inhibitory activity of beta-amino alcohol thiolactone-chalcone and isatin-chalcone hybrids.
Topics: Antimalarials; Chalcone; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Isatin; Lactones; Malaria, Falciparum; Plasmodium falciparum; Triazoles | 2010 |
Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds.
Topics: Alkynes; Aminoquinolines; Animals; Antimalarials; Azides; Catalysis; Chalcone; Chalcones; Copper; Drug Design; Hemin; Nucleosides; Plasmodium falciparum; Quinolines; Structure-Activity Relationship; Triazoles | 2010 |
1,2,3-Triazole tethered β-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation.
Topics: Antineoplastic Agents; beta-Lactams; Cell Line, Tumor; Cell Proliferation; Chalcone; Humans; Inhibitory Concentration 50; Triazoles | 2012 |
Synthesis and in vitro anti-tubercular evaluation of 1,2,3-triazole tethered β-lactam-ferrocene and β-lactam-ferrocenylchalcone chimeric scaffolds.
Topics: Antitubercular Agents; beta-Lactams; Chalcone; Chemistry Techniques, Synthetic; Ferrous Compounds; Metallocenes; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Triazoles | 2012 |
Azide-alkyne cycloaddition en route towards 1H-1,2,3-triazole-tethered β-lactam-ferrocene and β-lactam-ferrocenylchalcone conjugates: synthesis and in vitro anti-tubercular evaluation.
Topics: Alkynes; Antitubercular Agents; Azides; beta-Lactams; Chalcone; Copper; Cycloaddition Reaction; Ferrous Compounds; Metallocenes; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2013 |
Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents.
Topics: Antimalarials; Antineoplastic Agents; Cell Line, Tumor; Chalcone; Chemistry Techniques, Synthetic; Coumarins; Cysteine Endopeptidases; Humans; Molecular Docking Simulation; Plasmodium falciparum; Protein Conformation; Triazoles; Tubulin | 2014 |
Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity.
Topics: alpha-Glucosidases; Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Chemistry Techniques, Synthetic; DNA Topoisomerases, Type II; DNA-Binding Proteins; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Protein Conformation; Rats; Structure-Activity Relationship; Tissue Distribution; Triazoles | 2015 |
Design, synthesis and anticancer activity of matrine-1H-1,2,3-triazole-chalcone conjugates.
Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chalcone; Drug Design; Drug Screening Assays, Antitumor; Fluorouracil; HeLa Cells; Humans; Male; Matrines; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; NIH 3T3 Cells; Quinolizines; Structure-Activity Relationship; Transplantation, Heterologous; Triazoles | 2015 |
Click reaction based synthesis, antimicrobial, and cytotoxic activities of new 1,2,3-triazoles.
Topics: Anti-Infective Agents; Aspergillus flavus; Bacteria; Candida albicans; Cell Line, Tumor; Cell Survival; Chalcone; Click Chemistry; Escherichia coli; Fungi; Humans; Microbial Sensitivity Tests; Quinolines; Staphylococcus aureus; Triazoles | 2015 |
Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Cell Line, Tumor; Chalcone; Dose-Response Relationship, Drug; Flavones; Fungi; Humans; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Triazoles | 2016 |
4-Aminoquinoline-ferrocenyl-chalcone conjugates: Synthesis and anti-plasmodial evaluation.
Topics: Aminoquinolines; Animals; Antimalarials; Antiparasitic Agents; Chalcone; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Ferrous Compounds; Humans; Metallocenes; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Structure-Activity Relationship; Triazoles | 2017 |
1H-1,2,3-triazole-tethered uracil-ferrocene and uracil-ferrocenylchalcone conjugates: Synthesis and antitubercular evaluation.
Topics: Antitubercular Agents; Catalysis; Cell Survival; Chalcone; Copper; Ferrous Compounds; HeLa Cells; Humans; Metallocenes; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Uracil | 2017 |
Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chalcone; Chemistry Techniques, Synthetic; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Green Chemistry Technology; Humans; M Phase Cell Cycle Checkpoints; Membrane Potential, Mitochondrial; Structure-Activity Relationship; Triazoles; Water | 2017 |
Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcone; Colchicine; Drug Design; ErbB Receptors; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Quinoxalines; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Triazoles; Tubulin; Tubulin Modulators | 2017 |
Design, synthesis, characterization, antimicrobial evaluation and molecular modeling studies of some dehydroacetic acid-chalcone-1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Bacillus subtilis; Candida albicans; Chalcone; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pseudomonas aeruginosa; Pyrones; Staphylococcus epidermidis; Structure-Activity Relationship; Triazoles | 2018 |
Synthesis, crystal structure and antimicrobial potential of some fluorinated chalcone-1,2,3-triazole conjugates.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Bacillus subtilis; Candida albicans; Chalcone; Crystallography, X-Ray; Dose-Response Relationship, Drug; Escherichia coli; Halogenation; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pseudomonas aeruginosa; Staphylococcus epidermidis; Structure-Activity Relationship; Triazoles | 2018 |
Synthesis, characterization and application of copper oxide chitosan nanocomposite for green regioselective synthesis of [1,2,3]triazoles.
Topics: Azides; Catalysis; Chalcone; Chitosan; Copper; Cycloaddition Reaction; Green Chemistry Technology; Models, Molecular; Molecular Conformation; Nanocomposites; Triazoles | 2019 |
Anti-cancer potential of novel glycosylated 1,4-substituted triazolylchalcone derivatives.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Chalcone; Click Chemistry; Cycloaddition Reaction; Drug Screening Assays, Antitumor; Female; Glycosylation; Humans; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Synthesis, Structure and In Vitro Cytotoxic Activity of Novel Cinchona-Chalcone Hybrids with 1,4-Disubstituted- and 1,5-Disubstituted 1,2,3-Triazole Linkers.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Chemistry Techniques, Synthetic; Cinchona; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Conformation; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Synthesis and anti-proliferative activity of a novel 1,2,3-triazole tethered chalcone acetamide derivatives.
Topics: Acetamides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship; Triazoles | 2020 |
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAF
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Structure; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Quinolines; Structure-Activity Relationship; Triazoles | 2021 |
Synthesis, antimicrobial activities, docking studies and computational calculations of new bis-1,4-phenylene -1
Topics: Anti-Infective Agents; Chalcone; Microbial Sensitivity Tests; Structure-Activity Relationship; Triazoles; Ultrasonics | 2022 |
Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Drug Screening Assays, Antitumor; Humans; Leukemia; Molecular Docking Simulation; Molecular Structure; Poly(ADP-ribose) Polymerase Inhibitors; Structure-Activity Relationship; Triazoles | 2022 |
New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization.
Topics: Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Ciprofloxacin; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Polymerization; Structure-Activity Relationship; Triazoles; Tubulin | 2022 |
Synthesis, Biological Activity and Molecular Docking Studies of Heterocyclic Chalcones.
Topics: Aldehydes; Anti-Infective Agents; Antineoplastic Agents; Candida albicans; Chalcone; Chalcones; Imidazoles; Indoles; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship; Thiophenes; Triazoles | 2022 |
Design, synthesis, and modelling study of new 1,2,3-triazole/chalcone hybrids with antiproliferative action as epidermal growth factor receptor inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Doxorubicin; Drug Screening Assays, Antitumor; ErbB Receptors; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Structure-Activity Relationship; Triazoles | 2023 |
New Chalcone-Triazole Hybrids with Promising Antimicrobial Activity in Multidrug Resistance Strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Chalcone; Chalcones; Drug Resistance, Multiple; Humans; Methicillin-Resistant Staphylococcus aureus; Salmonella typhimurium; Staphylococcal Infections; Triazoles | 2022 |
Novel Chalcone-Phenazine Hybrids Induced Ferroptosis in U87-MG Cells through Activating Ferritinophagy.
Topics: Autophagy; Chalcone; Chalcones; Ferroptosis; Phenazines; Triazoles | 2023 |
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents
Topics: Adolescent; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Child; Drug Screening Assays, Antitumor; Humans; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Triazoles | 2022 |
Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms.
Topics: Antineoplastic Agents; Apoptosis; Cell Death; Cell Line, Tumor; Chalcone; Chalcones; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Necrosis; Squamous Cell Carcinoma of Head and Neck; Triazoles | 2023 |